NRobotics Co Supply Chain
Supply Chain of NRobotics Co (138360.KQ) as of Oct 16, 2026.
Get this data via API
Financial Data API
Supply Chain
-
Last updated:
Supply chains in stock corporations are essential components of business infrastructure and play a crucial role in value creation and competitiveness. These supply chains encompass all steps from raw material procurement and production to the delivery of finished products to the end customer.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
NRobotics Co Stock analysis
What does NRobotics Co do? NRobotics Co Ltd, trading under the ticker symbol 138360.KQ and identified by the ISIN KR7138360003, is a South Korean enterprise operating within the Materials sector, specifically in the Chemicals industry. The company maintains its corporate headquarters in Siheung, located in the Gyeonggi-Do province. As of the most recent data, the organization employs a workforce of 45 full-time staff members, reflecting its status as a small-to-medium sized entity in the chemical manufacturing landscape. NRobotics Co Ltd officially entered the public markets through an initial public offering on November 8, 2013, marking a significant milestone in its corporate history and financial transparency. The company’s primary business activity revolves around the manufacture and sale of cosmetic ingredients, serving a diverse range of clients in the beauty and personal care industries. Its product portfolio is extensive and technologically advanced, featuring bioconversion technology products, encapsulated products, natural extracts, and synthetic compounds. Among its notable offerings are specialized formulations such as Aquatouch L, a blend composed of glycerin, dimethicone, water, and lecithin, designed to enhance skin hydration and texture. Another key product is Silkytouch L, which combines water, dimethicone, glycerin, palmitoyl inulin, behenyl alcohol, and 1,2-hexanediol to provide smooth application and sensory benefits. The company also produces a range of phyto-based ingredients, including Phytoact Reliefer, which utilizes phaseolus radiates seed extract and avena sativa meal extract, alongside other active components like ethyhexylglycerin. Further innovations in the natural extract segment include Actosome InoCeramide E06, Actosome Retinol850, Actosome Retinal Palmitate, Actostem GinElixir, and Actosome Deage, each targeted at specific cosmetic efficacy needs such as anti-aging and skin barrier support. In addition to its core cosmetic ingredient business, NRobotics Co Ltd has diversified its operations to include the provision of electronic materials, indicating a strategic expansion into adjacent high-tech sectors. This diversification underscores the company’s commitment to leveraging its chemical expertise across multiple industrial applications. Despite its relatively small employee base, the company’s focus on specialized, high-value ingredients and its presence in both cosmetic and electronic material markets position it as a niche player with potential for growth in specialized chemical supply chains. The company’s official web presence can be accessed at http://www.hjfm.co.kr/, where stakeholders and potential partners can find further details regarding its operations and product lines. NRobotics Co is one of the most popular companies on Eulerpool.
All Key Metrics — NRobotics Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth